Summary
- Current Price
- As of today, ARDS price is $0.00, up +850.00% on
- Current Price All-Time High
- ARDS price is currently -99.99% below its historical high of $13.85 set on
- Market Cap
- ARDS current market cap is $85K, up +1800.00% over the past 365 days
- PE Ratio
- ARDS PE ratio is unknown
- Revenue
- ARDS current annual revenue is $3.09M, up +101.37% year-over-year
- Next Earnings
- As of today, the next earnings release for ARDS has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Aridis Pharmaceuticals, Inc. |
| Ticker | NASDAQ: ARDS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | aridispharma.com |
| Employees | 37 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| Price, 1D Change | +850.00% | |
| $85K | ||
| - | ||
| - | ||
| -12.04 | ||
| $3M | ||
| Revenue, 1Y Change | +101.37% | |
| -$1.62 | ||
| EPS, 1Y Change | +57.08% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.62 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $3.09M | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $0.00 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.76 | N/A | - | |
| - | N/A | - | |
| - | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.19M | N/A | - | |
| - | N/A | - | |
| $7.60M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +1,800.00% | ||
| -99.68% | ||
| +1,800.00% | ||
| -99.48% | ||
| +101.37% | ||
| +202.45% | ||
| +57.08% | ||
| +53.91% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| $0.00 | ||
| SMA 200 vs Price | -73.68% | |
| $0.00 | ||
| SMA 50 vs Price | -63.16% | |
| -12.04 | ||
| $0.00 | ||
| 53.33 | ||
| 4,343.54% | ||
| 3,602.81% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $3.09M | ||
| -$1.62 | ||
| $2.60M | ||
| 84.24% | ||
| -$29.99M | ||
| -970.33% | ||
| -$30.37M | ||
| -982.56% | ||
| -$29.51M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -0.25 | ||
| 0.26 | ||
| 0.26 | ||
| - | ||
| 4 | ||
| -27.39 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 0.00 | ||
| -0.01 | ||
| -8.52 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$24.23M | ||
| $5.06M | ||
| $14.70M | ||
| $9.64M | ||
| $38.93M | ||
| $36.90M | ||
| $6.13M | ||
| $4.84M | ||
| $2.31M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $33.46M | ||
| $32.60M | ||
| $487.00K | ||
| $7.16M | ||
| $487.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$29.13M | ||
| -$82.00K | ||
| $14.78M | ||
| $82.00K | ||
| -$29.21M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | ||
| Maxim Group | → | |
| HC Wainwright & Co. | ||
| HC Wainwright & Co. | ||
| H.C. Wainwright | ||
| Roth Capital | ||
| HC Wainwright & Co. | ||
| H.C. Wainwright |
Analyst sentiment
Institutional ownership
Screeners with ARDS
FAQ
What is the ticker symbol for Aridis Pharmaceuticals, Inc.?
The ticker symbol for Aridis Pharmaceuticals, Inc. is NASDAQ:ARDS
Does Aridis Pharmaceuticals, Inc. pay dividends?
No, Aridis Pharmaceuticals, Inc. does not pay dividends
What sector is Aridis Pharmaceuticals, Inc. in?
Aridis Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Aridis Pharmaceuticals, Inc. in?
Aridis Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Aridis Pharmaceuticals, Inc. based in?
Aridis Pharmaceuticals, Inc. is headquartered in United States
When did Aridis Pharmaceuticals, Inc. go public?
Aridis Pharmaceuticals, Inc. initial public offering (IPO) was on August 14, 2018
Is Aridis Pharmaceuticals, Inc. in the S&P 500?
No, Aridis Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Aridis Pharmaceuticals, Inc. in the NASDAQ 100?
No, Aridis Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Aridis Pharmaceuticals, Inc. in the Dow Jones?
No, Aridis Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Aridis Pharmaceuticals, Inc. last earnings report?
Aridis Pharmaceuticals, Inc.'s most recent earnings report was on November 10, 2022
When does Aridis Pharmaceuticals, Inc. report earnings?
The date for Aridis Pharmaceuticals, Inc.'s next earnings report has not been announced yet
Data Sources & References
- ARDS Official Website www.aridispharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1614067/000149315223039521/0001493152-23-039521-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1614067/000149315223018590/0001493152-23-018590-index.htm
- ARDS Profile on Yahoo Finance finance.yahoo.com/quote/ARDS
- ARDS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ards